FitLife Brands (FTLF) Competitors $15.70 +0.44 (+2.85%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends FTLF vs. AUTL, PHAR, HUMA, MNMD, XERS, ANAB, RNAC, TRDA, ERAS, and MLYSShould you be buying FitLife Brands stock or one of its competitors? The main competitors of FitLife Brands include Autolus Therapeutics (AUTL), Pharming Group (PHAR), Humacyte (HUMA), Mind Medicine (MindMed) (MNMD), Xeris Biopharma (XERS), AnaptysBio (ANAB), Cartesian Therapeutics (RNAC), Entrada Therapeutics (TRDA), Erasca (ERAS), and Mineralys Therapeutics (MLYS). These companies are all part of the "pharmaceutical products" industry. FitLife Brands vs. Autolus Therapeutics Pharming Group Humacyte Mind Medicine (MindMed) Xeris Biopharma AnaptysBio Cartesian Therapeutics Entrada Therapeutics Erasca Mineralys Therapeutics Autolus Therapeutics (NASDAQ:AUTL) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, institutional ownership, risk, profitability, community ranking and earnings. Which has stronger earnings and valuation, AUTL or FTLF? FitLife Brands has higher revenue and earnings than Autolus Therapeutics. Autolus Therapeutics is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAutolus Therapeutics$1.70M306.79-$208.38M-$1.21-1.62FitLife Brands$52.70M1.37$5.30M$1.699.29 Do analysts prefer AUTL or FTLF? Autolus Therapeutics currently has a consensus price target of $10.40, suggesting a potential upside of 430.61%. FitLife Brands has a consensus price target of $20.00, suggesting a potential upside of 27.39%. Given Autolus Therapeutics' higher possible upside, analysts plainly believe Autolus Therapeutics is more favorable than FitLife Brands.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Autolus Therapeutics 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00FitLife Brands 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Is AUTL or FTLF more profitable? FitLife Brands has a net margin of 13.38% compared to Autolus Therapeutics' net margin of 0.00%. FitLife Brands' return on equity of 28.03% beat Autolus Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Autolus TherapeuticsN/A -63.65% -36.54% FitLife Brands 13.38%28.03%15.13% Which has more risk and volatility, AUTL or FTLF? Autolus Therapeutics has a beta of 2.02, suggesting that its share price is 102% more volatile than the S&P 500. Comparatively, FitLife Brands has a beta of 0.96, suggesting that its share price is 4% less volatile than the S&P 500. Do insiders and institutionals hold more shares of AUTL or FTLF? 72.8% of Autolus Therapeutics shares are owned by institutional investors. Comparatively, 2.3% of FitLife Brands shares are owned by institutional investors. 25.7% of Autolus Therapeutics shares are owned by insiders. Comparatively, 61.3% of FitLife Brands shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the MarketBeat Community believe in AUTL or FTLF? Autolus Therapeutics received 225 more outperform votes than FitLife Brands when rated by MarketBeat users. Likewise, 67.96% of users gave Autolus Therapeutics an outperform vote while only 50.00% of users gave FitLife Brands an outperform vote. CompanyUnderperformOutperformAutolus TherapeuticsOutperform Votes22767.96% Underperform Votes10732.04% FitLife BrandsOutperform Votes250.00% Underperform Votes250.00% Does the media prefer AUTL or FTLF? In the previous week, FitLife Brands had 2 more articles in the media than Autolus Therapeutics. MarketBeat recorded 4 mentions for FitLife Brands and 2 mentions for Autolus Therapeutics. FitLife Brands' average media sentiment score of 0.84 beat Autolus Therapeutics' score of -0.04 indicating that FitLife Brands is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Autolus Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral FitLife Brands 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryFitLife Brands beats Autolus Therapeutics on 12 of the 19 factors compared between the two stocks. Get FitLife Brands News Delivered to You Automatically Sign up to receive the latest news and ratings for FTLF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FTLF vs. The Competition Export to ExcelMetricFitLife BrandsMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$72.38M$1.19B$5.67B$9.04BDividend YieldN/AN/A5.31%4.00%P/E Ratio9.2937.7890.3619.28Price / Sales1.375.811,036.8679.91Price / Cash19.3910.8846.0938.87Price / Book2.581.815.135.00Net Income$5.30M-$53.22M$113.24M$222.75M7 Day Performance2.45%-4.84%-0.98%-0.57%1 Month Performance5.48%-1.82%4.19%3.01%1 Year Performance42.73%-12.67%21.69%17.84% FitLife Brands Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FTLFFitLife Brands4.3739 of 5 stars$15.70+2.9%$20.00+27.4%+35.6%$72.38M$52.70M9.2920Stock SplitShort Interest ↑AUTLAutolus Therapeutics2.9025 of 5 stars$2.11-4.5%$10.40+392.9%-70.1%$561.46M$10.09M-1.74330Short Interest ↑PHARPharming Group3.1092 of 5 stars$8.20-6.4%$27.00+229.3%-23.6%$557.85M$245.32M-31.54280Short Interest ↓HUMAHumacyte3.2113 of 5 stars$4.30-6.1%$13.71+218.9%+10.5%$541.20M$1.57M-3.21150Short Interest ↓Gap DownMNMDMind Medicine (MindMed)2.1929 of 5 stars$7.37+8.5%$26.33+257.3%+86.6%$540.44MN/A-3.2640Gap DownXERSXeris Biopharma3.7482 of 5 stars$3.59+0.8%$5.15+43.5%+24.0%$535.20M$163.91M-7.98290Positive NewsGap DownANABAnaptysBio3.8384 of 5 stars$16.66-7.1%$41.45+148.8%-46.2%$506.96M$17.16M-2.74100Short Interest ↓Trading HaltedRNACCartesian Therapeutics2.5759 of 5 stars$19.89+3.0%$42.86+115.5%-9.2%$505.60M$26M-0.3864Analyst RevisionPositive NewsTRDAEntrada Therapeutics3.2501 of 5 stars$13.33-0.8%$25.67+92.5%-19.1%$498.81M$129.01M8.38110ERASErasca2.5798 of 5 stars$1.76-6.9%$5.70+223.9%-14.1%$497.61MN/A-2.12120MLYSMineralys Therapeutics2.8095 of 5 stars$9.93-3.6%$30.00+202.1%-34.4%$494.22MN/A-3.0428Earnings ReportNews CoverageGap Up Related Companies and Tools Related Companies Autolus Therapeutics Competitors Pharming Group Competitors Humacyte Competitors Mind Medicine (MindMed) Competitors Xeris Biopharma Competitors AnaptysBio Competitors Cartesian Therapeutics Competitors Entrada Therapeutics Competitors Erasca Competitors Mineralys Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:FTLF) was last updated on 2/12/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored New Options "Trading GPS" = 91% Win-RateThink of it as GPS navigation for the options market... Even traders who previously found options "too comp...Eagle Publishing | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredMarket down? Do this now.The Trump administration's new tariffs have already begun to shake the economy. The impact is real, and the cl...Colonial Metals | SponsoredTrump Policies Are Going to Light a Fire Under GoldHow You Can Profit from Trump's Bold Moves in 2025 Donald Trump’s bold policies are creating unprecedented ...Golden Portfolio | SponsoredMust-See: Trump’s Shocking AI AnnouncementIf you have any investments in AI stocks or are interested in AI… Please take a moment to review the detail...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FitLife Brands, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FitLife Brands With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.